This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, University of Aberdeen. Active years: 2020-2022.
Company Filing History:
3 out of 3,691 
3 out of 51 
Years Active: 2020-2022
Title: Shaunna Beedie: Innovator in Thalidomide Analog Research
Introduction
Shaunna Beedie is a prominent inventor based in Aberdeen, GB. She has made significant contributions to the field of pharmaceuticals, particularly through her work on thalidomide analogs. With a total of three patents to her name, Beedie's research focuses on developing compounds that exhibit anti-angiogenic and anti-inflammatory properties.
Latest Patents
Beedie's latest patents include innovative methods of using thalidomide analogs. These compounds are designed to provide therapeutic benefits while ensuring they are non-teratogenic. The disclosed methods highlight the potential of these analogs in treating various medical conditions by targeting specific biological pathways.
Career Highlights
Throughout her career, Shaunna Beedie has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and the University Court of the University of Aberdeen. Her work in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Beedie has collaborated with notable colleagues, including Nigel H. Greig and Weiming Luo. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of her research.
Conclusion
Shaunna Beedie's innovative work in thalidomide analogs showcases her dedication to advancing medical science. Her contributions are paving the way for new therapeutic options and highlight the importance of research in improving health outcomes.